56 Article(s)Download |
||||||
PMID | Title | Pub. Year | #Total Relationships |
|||
1 | 27088320 | Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine. | 2016 Jul 17 | 1 | ||
2 | 21087377 | Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal. | 2011 Feb | 1 | ||
3 | 19207595 | Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy. | 2009 Mar | 3 | ||
4 | 19432547 | Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. | 2009 Jun 1 | 1 | ||
5 | 19737231 | Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone. | 2009 Oct | 1 | ||
6 | 18546542 | Predictors of CD4+ cell count response and of adverse outcome among HIV-infected patients receiving highly active antiretroviral therapy in a public hospital in Peru. | 2008 May | 2 | ||
7 | 17341536 | CD4+ cell count decline despite HIV suppression: a probable didanosine-valganciclovir interaction. | 2007 Mar | 6 | ||
8 | 17434879 | CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. | 2007 Jun | 1 | ||
9 | 18025882 | Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy. | 2007 Nov 30 | 1 | ||
10 | 16531427 | Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | 2006 May | 2 | ||
11 | 16717052 | Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. | 2006 Jul | 1 | ||
12 | 16956530 | [Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression]. | 2006 Aug-Sep | 7 | ||
13 | 15802975 | Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine. | 2005 Mar 24 | 1 | ||
14 | 15865227 | Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. | 2005 | 1 | ||
15 | 15958845 | Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. | 2005 Jul 1 | 4 | ||
16 | 16107993 | Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies. | 2005 Sep 15 | 1 | ||
17 | 16312178 | Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial. | 2005 | 1 | ||
18 | 15090798 | Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load. | 2004 Feb 20 | 3 | ||
19 | 15259896 | Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach. | 2004 Jun | 1 | ||
20 | 15622326 | CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related. | 2004 Dec 3 | 1 | ||
21 | 12803944 | Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. | 2003 May | 1 | ||
22 | 11865396 | T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. | 2002 Feb 15 | 1 | ||
23 | 12215207 | L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. | 2002 Jun | 1 | ||
24 | 10671348 | Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy. | 2000 Feb | 1 | ||
25 | 11101059 | Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the scan study. | 2000 Nov 10 | 1 | ||
26 | 9928724 | A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. | 1999 Jan 1 | 1 | ||
27 | 10395849 | The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus. | 1999 Aug | 1 | ||
28 | 10428106 | Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team. | 1999 Aug 1 | 1 | ||
29 | 10534145 | Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. | 1999 Sep 1 | 1 | ||
30 | 10651392 | Didanosine: an updated review of its use in HIV infection. | 1999 Dec | 2 | ||
31 | 16021874 | Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients. | 1999 | 1 | ||
32 | 10503166 | A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. | 1998 | 2 | ||
33 | 11322267 | Zidovudine plus didanosine in primary HIV-1 infection. | 1997 Jan | 1 | ||
34 | 11327443 | Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. | 1997 Dec | 1 | ||
35 | 8556398 | Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection. | 1996 Feb 1 | 2 | ||
36 | 8603961 | Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial. | 1996 Apr | 1 | ||
37 | 8605592 | Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV. | 1996 Apr 15 | 2 | ||
38 | 8673528 | Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group. | 1996 Jul | 1 | ||
39 | 8898668 | A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team. | 1996 Nov 1 | 2 | ||
40 | 8997487 | Retroviral proteases: structure, function and inhibition from a non-anticipated viral enzyme to the target of a most promising HIV therapy. | 1996 Dec | 1 | ||
41 | 11322250 | Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients. | 1996 Aug | 2 | ||
42 | 7677296 | Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group. | 1995 Oct 15 | 4 | ||
43 | 7718186 | Response of HIV RNA to didanosine as a predictive marker of survival. | 1995 Feb | 1 | ||
44 | 7751692 | Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infection. | 1995 May | 1 | ||
45 | 8595509 | Studies of zidovudine in combination with didanosine and zalcitabine. | 1995 | 2 | ||
46 | 8721897 | A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3. | 1995 | 4 | ||
47 | 7840911 | HIV therapy advances. Pediatric antiretroviral choices. | 1994 Sep | 2 | ||
48 | 7888537 | Rates and risk factors for adverse events associated with didanosine in the expanded access program. | 1994 Dec | 1 | ||
49 | 7905722 | Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. | 1994 Mar 1 | 1 | ||
50 | 8093845 | Relation between plasma concentrations of didanosine and markers of antiviral efficacy in adults with AIDS or AIDS-related complex. | 1993 Feb | 1 |